Yes, weed is a drug by every major definition of the word. It meets the scientific criteria for a psychoactive substance, it’s classified as a controlled substance under U.S. federal law, and the World Health Organization identifies it as the most commonly used psychoactive substance under international control. That said, the word “drug” covers an enormous range of substances, from caffeine to morphine, so calling weed a drug doesn’t tell you much on its own. The more useful question is what kind of drug it is and what that means in practice.
What Makes Something a Drug
In pharmacology, a drug is any substance that changes how your body or mind functions when you consume it. Cannabis qualifies because its main active compound, THC, alters mood, thoughts, and perception of reality. It does this by binding to specific receptors in the brain and throughout the body, the same receptors your body’s own signaling molecules use to regulate things like pain, appetite, memory, and mood.
Your brain has a built-in network called the endocannabinoid system. THC mimics the natural chemicals in this system and activates receptors concentrated in areas responsible for thinking, memory, coordination, and pleasure. That’s why getting high produces the effects it does: altered time perception, heightened sensory experience, changes in mood, and impaired short-term memory. CBD, the other well-known compound in cannabis, interacts with some of the same receptors but doesn’t produce intoxication. The cannabis plant contains over 100 different cannabinoid compounds in total.
How U.S. Law Classifies Weed
Under the Controlled Substances Act, marijuana is currently a Schedule I controlled substance. That’s the most restrictive category, shared with heroin and ecstasy. Schedule I means the federal government considers it to have a high potential for abuse and no currently accepted medical use, though that second point is increasingly contested.
A proposal to move marijuana from Schedule I to Schedule III has been working its way through the federal system. The Department of Justice published a formal notice of proposed rulemaking in 2024, and DEA hearings on the matter began in January 2025. Schedule III would place cannabis alongside substances like testosterone and certain codeine formulations, acknowledging medical applications while keeping it regulated. As of now, however, marijuana remains Schedule I at the federal level.
There’s one important legal distinction within the cannabis plant itself. The 2018 Farm Bill separated “hemp” from “marijuana” based on THC content. Hemp, defined as cannabis with a total THC concentration below 0.3% by dry weight, was removed from the Controlled Substances Act entirely. Anything above that threshold is still federally classified as marijuana. This is why you can buy CBD products in most states while marijuana remains illegal under federal law.
How It’s Classified Internationally
Cannabis sits under the United Nations Single Convention on Narcotic Drugs, an international treaty that governs controlled substances worldwide. In December 2020, the UN Commission on Narcotic Drugs voted to reclassify cannabis to recognize its therapeutic potential, placing it alongside substances like morphine and oxycodone in terms of its acknowledged abuse and dependence risk. The reclassification removed some international barriers to medical research but did not change the substance’s status for non-medical use. Cannabis remains under strict international control.
FDA-Approved Cannabis Medications
While whole-plant marijuana lacks federal approval as medicine, several cannabis-derived and cannabis-related drugs have been approved by the FDA. Epidiolex, a purified CBD product, is prescribed for severe seizure disorders in patients two years and older. Three synthetic versions of THC are also approved: two containing dronabinol (a lab-made form of THC) for chemotherapy-related nausea and AIDS-related weight loss, and one containing nabilone, a compound chemically similar to THC, also for chemotherapy nausea. All require a prescription.
These approvals are significant because they demonstrate that compounds from cannabis have recognized medical value when isolated, standardized, and tested through clinical trials. The gap between approved cannabinoid medications and whole-plant marijuana is largely about consistency and dosing: a pharmaceutical product delivers a precise amount of a specific compound, while the chemical profile of marijuana varies widely depending on strain, growing conditions, and preparation.
Dependence and Clinical Diagnosis
Cannabis can cause dependence in some users. The American Psychiatric Association recognizes cannabis use disorder in the DSM-5, the standard diagnostic manual for mental health conditions. A person is diagnosed when they meet two or more of the established criteria, which include things like using more than intended, unsuccessful attempts to cut back, cravings, continued use despite problems in relationships or daily life, and withdrawal symptoms.
Severity is graded by how many criteria a person meets: two to three indicates mild, four to five is moderate, and six or more is severe. Cannabis withdrawal was formally added as a recognized syndrome in the DSM-5, ending a long debate about whether it existed. Symptoms typically include irritability, sleep difficulties, decreased appetite, and restlessness, and they tend to peak within the first week after stopping.
Not everyone who uses cannabis develops a use disorder. Estimates vary, but the risk is real enough that clinicians screen for it the same way they would with alcohol or other substances.
Where Weed Sits Compared to Other Drugs
Calling weed a drug puts it in the same broad category as caffeine, alcohol, nicotine, prescription painkillers, and illegal narcotics. That category is wide, and the substances in it differ enormously in their risk profiles. Cannabis is less physically dangerous in overdose than alcohol or opioids. You cannot fatally overdose on THC alone in any realistic scenario. But it’s also not harmless: it can impair driving, affect developing brains in adolescents, trigger anxiety or paranoia at high doses, and lead to dependence with regular heavy use.
The cultural debate about whether weed “should” be considered a drug often reflects discomfort with the word itself. People associate “drug” with addiction and danger, so applying it to something millions of people use casually feels heavy-handed. But pharmacologically, the label is straightforward. Weed contains compounds that cross the blood-brain barrier, bind to receptors, and change how you think and feel. That’s what a drug does. Whether a given drug is mild or dangerous, legal or illegal, medical or recreational are all separate questions from whether it qualifies as one.